Cancer Education · Research
CAR-T Cell Therapy and Bispecific Antibodies Are Transforming Acute Lymphoblastic Leukemia
Ten years ago, ALL was a chemotherapy-heavy disease with poor long-term survival for many patient groups. That has changed dramatically.
By Thomas Knight, MD
